Methodology

All entries for: Transpire Bio Inc

September 3, 2025

Transpire Bio Inc

Orphan Drug Designation

FDA orphan drug designation: treatment of idiopathic pulmonary fibrosis (IPF)

Disease Area: Rare Diseases